Vimarsana
Biggest News Aggregation in the World

Page 2 - Red Journal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Red Journal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Red Journal Today - Breaking & Trending Today

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care - Vimarsana News

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care

A new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives were driven almost entirely by a type of treatment given to fewer than 1 in 5 patients.

2022-11-22 | NDAQ:DRTS | Press Release | Alpha Tau Medical Ltd. - Vimarsana News

2022-11-22 | NDAQ:DRTS | Press Release | Alpha Tau Medical Ltd.

(2022-11-22 | NDAQ:DRTS) Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Novocure (NVCR) Q3 2022 Earnings Call Transcript - Vimarsana News

Novocure (NVCR) Q3 2022 Earnings Call Transcript

NVCR earnings call for the period ending September 30, 2022.

Source: fool.com
'Bold, beacon, boom': Outgoing president touts ACG legacy in diversity, representation - Vimarsana News

'Bold, beacon, boom': Outgoing president touts ACG legacy in diversity, representation

CHARLOTTE, N.C. — As his presidency comes to a close, Samir A. Shah, MD, FACG, reflected on the progress made during his tenure, with significant strides in expanding representation and diversity within ACG. “One year ago, when I accepted the role of president, I highlighted three words to guide my year of service: bold, beacon and boom,” Shah, clinical professor of medicine at

Source: healio.com
PreludeDx™ Presents DCISionRT® Data in Oral Presentation at the American Society for Radiation Oncology Annual Meeting - Vimarsana News

PreludeDx™ Presents DCISionRT® Data in Oral Presentation at the American Society for Radiation Oncology Annual Meeting

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced study...